
In comparison with watchful waiting, the new drug Enzalutamide can prolong survival in certain patients with prostate cancer and delay the occurrence of disease complications, a new study concludes.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/B_7yXohExU0/150410113557.htm